This page shows the latest AndroGel news and features for those working in and with pharma, biotech and healthcare.
Among other products, HIV therapy Kaletra (lopinavir/ ritonavir) rose 1.1 per cent to $278m, while revenue from testosterone replacement therapy AndroGel fell 6.5 per cent to $258m.
involving testosterone replacement therapy product AndroGel should be allowed to go forward.
Top of the list in the speciality division is testosterone replacement therapy AndroGel – 31 per cent to $1.15bn in 2012 – with support from Creon (pancrelipase) for pancreatic insufficiency and hypothyroidism
Solvay's product portfolio includes the testosterone gel AndroGel, the progesterone capsule Prometrium, and the pancreatic enzyme replacement therapy Creon (pancreatin).
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
This is not the first such case for Teva, as the FTC also filed suit last September for an alleged pay for delay relating to AndroGel.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...